Joint Formulary & PAD

Lidocaine - Local anaesthesia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Injection
Associated Icons :
SPC
Restrictions / Comments :
Important

1% and 2% injection.
Note - 0.5% injection also used at RSFT and SASH

 

Status 2

Red
Formulations :
  • Oromucosal spray
Associated Icons :
SPC
Restrictions / Comments :
Important
10% mucosal spray

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Lidocaine
Indication :
Local anaesthesia
Group Name :
Keywords :
local anaesthetics
Brand Names Include :
Xylocaine
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Committee Recommendations (1)

This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.

See “Formulary Status” to identify where this drug has been agreed for use.